Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia

Enrique Gomez-Pomar1, Emily Hatfield2, Karen Garlitz3

  • 1Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky.

Insights

Some preterm infants still develop hemolytic anemia despite vitamin E supplementation. Those with low hematocrit and high reticulocyte counts may benefit from additional vitamin E therapy.

Area of Science:

  • Neonatalogy
  • Hematology
  • Nutritional Science

Background:

  • Vitamin E deficiency is linked to hemolytic anemia in premature infants.
  • Supplementation in preterm formulas and parenteral nutrition reduced incidence.
  • Some infants still develop hemolytic anemia requiring treatment.

Purpose of the Study:

  • To identify factors associated with vitamin E treatment response in preterm infants with hemolytic anemia.
  • To determine predictors of adequate response to vitamin E therapy.

Main Methods:

  • Retrospective analysis of 70 preterm infants with hemolytic anemia treated with vitamin E.
  • Infants classified into responders and non-responders.
  • Descriptive statistics and marginal logistic regression used.

Main Results:

  • Low hematocrit and high reticulocytosis before treatment predicted adequate response.
  • Hematocrit ≤26% and reticulocyte count ≥36.1% were associated with better response.
  • Short duration of parenteral nutrition and oxygen use were not associated with response.

Conclusions:

  • Preterm infants may develop hemolytic anemia despite standard vitamin E supplementation.
  • Additional vitamin E may benefit infants with anemia, reticulocytosis, and oxygen requirements.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.5K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K